- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06034496
Cranial Electrotherapy Stimulation and Acute Stress
Cranial Electrotherapy Stimulation (CES) Influences on Acute Stress Responses
The goal of this study is to quantify the effects of 20 sessions of Cranial Electrotherapy Stimulation (CES) on measures of acute stress responses in Soldiers. The main question it aims to answer is how 20 sessions of CES will affect Soldiers' biochemical (salivary alpha amylase and cortisol), physiological (e.g., heart rate, heart rate variability, respiration rate), emotional (state anxiety), and behavioral (i.e., cognitive task performance) responses.
- On Day 1, participants will complete a baseline measure assessing their biochemical, physiological, emotional, and behavioral responses to a stressful lethal force decision making task.
- In the next four to six weeks, participants will complete 20 CES sessions.
- Within five days of completing the 20 CES sessions, participants will complete a follow-up measure assessing their biochemical, physiological, emotional, and behavioral responses to the same stressful lethal force decision making task they completed on Day 1.
Researchers will compare the Active CES group to the Sham CES group to see how 20 sessions of Active CES will affect the participants responses to their biochemical, physiological, emotional and behavioral responses relative to the Sham CES group.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Medford, Massachusetts, United States, 02155
- Tufts University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-40 years of age (17-40 if emancipated minor)
- Can sit and stand freely.
- Have not used or experienced CES administration in the past.
- Agree to have their data stored in a repository (database) for future use.
Exclusion Criteria:
- Use of prescription medications, other than oral contraceptives
Women only:
- Pregnant or plan to become pregnant during the study
- Nursing
History of:
- A neurological or psychological disorder (such as depression, anxiety disorders, migraines, cluster headaches, seizures, Post-traumatic stress disorder (PTSD) or panic attacks).
- Cardiac disease (including arrhythmia or fast or skipped heart beats).
- Implanted medical devices, such as pacemakers.
- Hypertension.
- Insomnia
- Head injury (including neurosurgery, concussion, TBI, skull fracture, hematoma)
- Illness that caused brain injury
- Any other brain-related condition (such as traumatic brain injury)
- Metal in the head (outside of mouth, such as shrapnel, surgical clips, or fragments from welding or metalwork)
- Implanted medical device (e.g., pacemaker, insulin pump)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Active CES
Active Cranial Electrotherapy Stimulation (CES)
|
Active CES group will receive a minimum of 250µA and up to 500µA depending on thresholding, once daily for 20 days (over the course of 4~6 weeks), 20 minutes per day.
Other Names:
|
|
Sham Comparator: Sham CES
Sham Cranial Electrotherapy Stimulation (CES)
|
Sham CES group will be identical to Active CES group with the exception of the device not administering any electrical current
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline in Heart Rate During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES to be completed within 4-6weeks
|
heart rate will be measured in beats per minute.
|
Baseline and follow-up session after 20 CES to be completed within 4-6weeks
|
|
Change From Baseline in Respiration Rate During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES to be completed within 4-6weeks
|
respiration rate will be measured in breaths per minute.
|
Baseline and follow-up session after 20 CES to be completed within 4-6weeks
|
|
Change From Baseline in Heart Rate Variability During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES to be completed within 4-6weeks
|
Heart rate variability will be measured in RMSSD.
|
Baseline and follow-up session after 20 CES to be completed within 4-6weeks
|
|
Change Over Time in Cortisol During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
|
Cortisol (µg/dL) will be measured through saliva samples.
Saliva samples will be taken at five time points, approximately 20 minute increments during the baseline and follow-up sessions.
|
Baseline and follow-up session after 20 CES completed within 4-6weeks
|
|
Change Over Time in Alpha Amylase During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
|
Alpha amylase (IU) will be measured through saliva samples.
Saliva samples will be taken at five time points, approximately 20 minute increments during the baseline and follow-up sessions.
|
Baseline and follow-up session after 20 CES completed within 4-6weeks
|
|
Change Over Time in State Trait Anxiety Inventory (STAI) Scores at Each Session From Baseline to Follow-up
Time Frame: At baseline, at each of the 20 CES sessions completed within 4-6weeks, and at follow-up to be completed within 5 days of last CES
|
STAI assesses both state and trait anxiety separately with each scale ranging from 20 to 80, with higher scores correlating with greater anxiety.
STAI-S is the State Trait Anxiety Inventory - State version, and STAI-T is the State Trait Anxiety Inventory - Trait version.
|
At baseline, at each of the 20 CES sessions completed within 4-6weeks, and at follow-up to be completed within 5 days of last CES
|
|
Change From Baseline in Recognition Memory
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
|
Recognition memory of previously learned targets while ignoring visually similar distractor objects will be measured and evaluated with percent accuracy.
|
Baseline and follow-up session after 20 CES completed within 4-6weeks
|
|
Change From Baseline in Spatial Orientation
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
|
Spatial orientation task will involve pointing towards a series of distant (out of visible range) landmarks in the virtual environment and estimating distance to those landmarks.
Spatial orientation will be calculated using mean absolute angular error.
Larger numbers correlate with higher error.
|
Baseline and follow-up session after 20 CES completed within 4-6weeks
|
|
Change From Baseline in Decision Making Accuracy
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
|
Participants will make lethal force decision making by shooting at threatening targets and allowing non-threatening targets to pass.
Decision making accuracy will be calculated using d prime.
Higher d prime correlates with better accuracy.
|
Baseline and follow-up session after 20 CES completed within 4-6weeks
|
|
Change From Baseline in Decision Making Reaction Time
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
|
Participants will make lethal force decision making by shooting at threatening targets and allowing non-threatening targets to pass.
Decision making reaction time to shoot at threatening targets will be measured in milliseconds.
|
Baseline and follow-up session after 20 CES completed within 4-6weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kana Okano, Ph.D., Tufts University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003572
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.